Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1431, 2004-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IFN- -1a, IFN- -1b, glatiramer acetate not warranted in MS
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :
Access to resources
Recommend
IFN- -1a, IFN- -1b, glatiramer acetate not warranted in MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 465, 2004-01 ,pp. :
IFN- treatment cost driver in relapsing-remitting MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
IFN- treatment cost driver in relapsing-remitting MS
Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. :
Ezetimibe monotherapy reduces LDL cholesterol in patients with HIV
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :